Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Breast Cancer Recurrence Risk Predicted by Immune-Related Germline Variants

Breast Cancer Recurrence Risk Predicted by Immune-Related Germline Variants

Nov 01, 2019
|
staff reporter

NEW YORK – A Canadian team has demonstrated that variants in the germline, mostly in genes related to the immune system, can help to find breast cancer patients at increased risk of disease recurrence. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Earlier in the US

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

How the Proteins Shape Up

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

Who's to Be First?

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

PNAS Papers on Ovarian Cancer, Retrotransposon Insertions in Cancer, Malaria Mosquitoes

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Featured Webinar

Five Things to Consider When Ordering NIPT

Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms. 

What's Popular?

In Sequencing

  1. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  2. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

  3. BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

  4. Recurrent SARS-CoV-2 Virus Mutations Do Not Increase Transmissibility, Study Finds

  5. Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.